Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help? Christopher McCabeRichard EdlinPeter Hall Leading Article 23 July 2013 Pages: 731 - 737
Protease Inhibitors for Hepatitis C: Economic Implications Stuart J. TurnerJack BrownJoseph A. Paladino Review Article 10 July 2013 Pages: 739 - 751
The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue Alan CarlottoVirginia L. HogsettStephen T. Sonis Review Article 21 August 2013 Pages: 753 - 766
Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions Denis GetsiosJenő P. MartonJames G. Xenakis Original Research Article 03 July 2013 Pages: 767 - 780
Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making Margreet FrankenFredrik NilssonMarc Koopmanschap Original Research Article 10 July 2013 Pages: 781 - 797
Costs of Parkinson’s Disease in a Privately Insured Population Scott J. JohnsonAnna KaltenboeckAndrew D. Siderowf Original Research Article Open access 02 August 2013 Pages: 799 - 806
Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective Anthony BentleySamantha GillardFernando Tricta Original Research Article Open access 20 July 2013 Pages: 807 - 822
Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States Reginald VillacortaJoel W. HayAndrew Messali Original Research Article 23 August 2013 Pages: 823 - 839